Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-making.
Gandara
David R
DR
Lara
Primo N
PN
Mack
Philip
P
Scagliotti
Giorgio
G
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000235:genetics; D003657:Decision Making; D066246:ErbB Receptors / Q000037:antagonists & inhibitors / Q000235:genetics; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000235:genetics; D009154:Mutation; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D013940:Thymidylate Synthase / Q000235:genetics
D047428:Protein Kinase Inhibitors; D013940:Thymidylate Synthase; D066246:ErbB Receptors